Trial intelligence / Profile preview

MDMA-assisted psychotherapy for restricting-type anorexia nervosa

MOH_2022-04-03_010398Phase 2Not yet recruiting

Sponsor
יוזמת חוקר
Start
Nov 2021
Modality
Small Molecules
Countries
1
01

Overview

Phase 2, open-label, single-arm trial of midomafetamine in anorexia nervosa (AN), sponsored by יוזמת חוקר. Planned start Nov 2021; status: not yet recruiting.

02

Drugs

midomafetamine
03

Conditions

anorexia nervosa (AN)

Beyond the preview

Go deeper on MOH_2022-04-03_010398.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on MOH_2022-04-03_010398.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call